QQQ   418.51 (-1.16%)
AAPL   164.99 (-1.23%)
MSFT   401.25 (-0.75%)
META   487.67 (-2.82%)
GOOGL   154.54 (-0.94%)
AMZN   176.26 (-1.65%)
TSLA   150.03 (+0.07%)
NVDA   817.75 (-3.42%)
AMD   149.59 (-3.54%)
NIO   3.86 (-3.50%)
BABA   68.89 (+0.01%)
T   16.29 (-0.24%)
F   12.09 (+0.25%)
MU   107.19 (-4.23%)
GE   150.22 (-1.78%)
CGC   7.68 (-1.92%)
DIS   111.75 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.77 (+1.50%)
PYPL   62.04 (-0.10%)
XOM   120.08 (+1.32%)
QQQ   418.51 (-1.16%)
AAPL   164.99 (-1.23%)
MSFT   401.25 (-0.75%)
META   487.67 (-2.82%)
GOOGL   154.54 (-0.94%)
AMZN   176.26 (-1.65%)
TSLA   150.03 (+0.07%)
NVDA   817.75 (-3.42%)
AMD   149.59 (-3.54%)
NIO   3.86 (-3.50%)
BABA   68.89 (+0.01%)
T   16.29 (-0.24%)
F   12.09 (+0.25%)
MU   107.19 (-4.23%)
GE   150.22 (-1.78%)
CGC   7.68 (-1.92%)
DIS   111.75 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.77 (+1.50%)
PYPL   62.04 (-0.10%)
XOM   120.08 (+1.32%)
QQQ   418.51 (-1.16%)
AAPL   164.99 (-1.23%)
MSFT   401.25 (-0.75%)
META   487.67 (-2.82%)
GOOGL   154.54 (-0.94%)
AMZN   176.26 (-1.65%)
TSLA   150.03 (+0.07%)
NVDA   817.75 (-3.42%)
AMD   149.59 (-3.54%)
NIO   3.86 (-3.50%)
BABA   68.89 (+0.01%)
T   16.29 (-0.24%)
F   12.09 (+0.25%)
MU   107.19 (-4.23%)
GE   150.22 (-1.78%)
CGC   7.68 (-1.92%)
DIS   111.75 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.77 (+1.50%)
PYPL   62.04 (-0.10%)
XOM   120.08 (+1.32%)
QQQ   418.51 (-1.16%)
AAPL   164.99 (-1.23%)
MSFT   401.25 (-0.75%)
META   487.67 (-2.82%)
GOOGL   154.54 (-0.94%)
AMZN   176.26 (-1.65%)
TSLA   150.03 (+0.07%)
NVDA   817.75 (-3.42%)
AMD   149.59 (-3.54%)
NIO   3.86 (-3.50%)
BABA   68.89 (+0.01%)
T   16.29 (-0.24%)
F   12.09 (+0.25%)
MU   107.19 (-4.23%)
GE   150.22 (-1.78%)
CGC   7.68 (-1.92%)
DIS   111.75 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.77 (+1.50%)
PYPL   62.04 (-0.10%)
XOM   120.08 (+1.32%)

NovoCure (NVCR) SEC Filings & 10K Form

$12.08
+0.03 (+0.25%)
(As of 11:27 AM ET)

Recent NovoCure SEC Filings

DateFilerForm TypeView
03/27/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:39 PM
NovoCure (Subject)
Shah Pritesh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:17 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:43 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:35 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
6:11 AM
NovoCure (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:05 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:06 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:28 AM
FMR LLC (Filed by)
NovoCure (Subject)
Form SC 13G/A
01/18/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:57 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2024
4:15 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:10 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:10 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:23 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
5:19 AM
Capital World Investors (Filed by)
NovoCure (Subject)
Form SC 13G/A
11/28/2023
6:30 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
5:15 AM
BAILLIE GIFFORD & CO (Filed by)
NovoCure (Subject)
Form SC 13G/A
11/08/2023
3:22 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
4:15 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/02/2023
3:20 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
6:03 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
3:23 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:24 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:24 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:40 PM
Cordova Ashley (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/27/2023
6:03 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
7:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
3:12 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:13 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:13 PM
Ben Arye Barak (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
Burke William Patrick (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.
06/06/2023
2:45 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
11:18 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
7:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
3:34 PM
NovoCure (Issuer)
Stafford Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2023
6:06 AM
NovoCure (Filer)
Form DEF 14A
04/24/2023
6:08 AM
NovoCure (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NVCR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners